Open AccessRole of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
Author(s) -
Mohamed Shaker,
Karim A. Abd El Tawab,
Khaled H. Abd El Tawab,
Mohamed Nabih EL-Gharib
Publication year - 2016
Publication title -
the egyptian journal of radiology and nuclear medicine /the egyptian journal of radiology and nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 13
eISSN - 2090-4762
pISSN - 0378-603X
DOI - 10.1016/j.ejrnm.2016.04.012
Subject(s) - medicine , hyperplasia , prostate , embolization , urology , international prostate symptom score , surgery , radiology , lower urinary tract symptoms , cancer
ObjectivesTo assess the feasibility and efficacy of prostatic artery embolization in relieving symptoms of benign prostatic hyperplasia.Materials and methodsIn a prospective study 28 patients with symptomatic benign prostatic hyperplasia were presented for prostatic artery embolization between June 2012 and June 2014. Patients age was 48–85years with mean age 68.5years±10.6SD. International Prostate Symptoms Score (IPSS) before intervention measured 20–35 with mean score 26.3±6.8SD. Prostatic volume before intervention ranged between 48 and 166cc3 with mean of 82.6±11.2SD.ResultsTechnical success was achieved in all cases (100%). All patients were followed for 6months after the procedure. IPSS improved at 6months in all patients with post embolization mean of 12.2±3.4SD with significant P value of 0.0006. Mean post-procedure prostatic volume at 6months was 49.8cc3±16.9SD with 39.7% mean volume reduction. No major complications were recorded. We achieved clinical success in 27 patients (96.4%) with only one non responding patient (3.6%).ConclusionProstatic artery embolization is a feasible technique and preliminary short-term results show promising high technical and clinical success rates in symptomatic patients with benign prostatic hyperplasia